Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes

Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes

US Patent 7741491 · Granted Jun 22, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Nanopillar field-effect and junction transistors with functionalized gate and ba2018
Nanopillar field-effect and junction transistors with functionalized gate and ba2018
Imidazopyridine derivatives, process for preparation thereof and therapeutic use2016
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic2015
Nanopillar field-effect and junction transistors with functionalized gate and ba2015
5-oxoisoxazoles as inhibitors of lipases and phospholipases2015
5-oxoisoxazoles as inhibitors of lipases and phospholipases2015
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases2015
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases2015
Azole derivatives in the form of lipase and phospholipase inhibitors2014
Imidazopyridine derivatives, process for preparation thereof and therapeutic use2014